Literature DB >> 32774033

Intraosseous infiltrations of Platelet-Rich Plasma for severe hip osteoarthritis: A pilot study.

Nicolás Fiz1, Diego Delgado2, Ane Garate2, Pello Sánchez2, Jaime Oraa1, Ane Miren Bilbao1, Jorge Guadilla1, Mikel Sánchez1,2.   

Abstract

OBJECTIVE: Addressing the subchondral bone through intraosseous infiltrations of Platelet-Rich Plasma (PRP) may improve the effectiveness of this technique for severe hip osteoarthritis (HOA).
METHODS: Forty patients with HOA degree 2 and 3 according to the Tönnis scale were recruited for this study. They were susceptible to a total hip arthroplasty, without response to previous treatment based on intraarticular infiltrations of PRP. Patients received a combination of intraosseous injections into the acetabulum and the femoral head, as well as intraarticular PRP infiltrations. The clinical outcome was evaluated at 2, 6 and 12 months using the Hip Osteoarthritis Outcome Score (HOOS) and the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index.
RESULTS: At 2, 6 and 12 months, patients had significant pain improvement according to HOOS pain, WOMAC pain, and VAS scores. After the treatment, the percentage of patients with minimal clinically important improvement was 40% (16 over 40 patients) at 2 months, 37.5% (15 over 40) at 6 months, and 40% (16 over 40) at 12 months.
Conclusion: The combination of intra-articular and intra-osseous infiltrations of PRP showed a pain reduction and improvement in hip joint functionality up to 12 months in patients with severe HOA, with no severe adverse effects.
© 2020 Delhi Orthopedic Association. All rights reserved.

Entities:  

Keywords:  Hip osteoarthritis (HOA); Intraosseous infiltration; Platelet-rich plasma (PRP); Treatment

Year:  2019        PMID: 32774033      PMCID: PMC7394798          DOI: 10.1016/j.jcot.2019.12.012

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  30 in total

1.  Intraosseous Infiltration of Platelet-Rich Plasma for Severe Hip Osteoarthritis.

Authors:  Nicolás Fiz; Juan Carlos Pérez; Jorge Guadilla; Ane Garate; Pello Sánchez; Sabino Padilla; Diego Delgado; Mikel Sánchez
Journal:  Arthrosc Tech       Date:  2017-06-19

Review 2.  Human-Based Biological and Biomimetic Autologous Therapies for Musculoskeletal Tissue Regeneration.

Authors:  Sabino Padilla; Mikel Sánchez; Gorka Orive; Eduardo Anitua
Journal:  Trends Biotechnol       Date:  2016-12-19       Impact factor: 19.536

3.  Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis.

Authors:  Luca Di Sante; Ciro Villani; Valter Santilli; Massimo Valeo; Emmalisa Bologna; Luca Imparato; Marco Paoloni; Annamaria Iagnocco
Journal:  Med Ultrason       Date:  2016-12-05       Impact factor: 1.611

Review 4.  A biological therapy to osteoarthritis treatment using platelet-rich plasma.

Authors:  Eduardo Anitua; Mikel Sánchez; Gorka Orive; Sabino Padilla
Journal:  Expert Opin Biol Ther       Date:  2013-06-12       Impact factor: 4.388

Review 5.  Platelet rich plasma, stromal vascular fraction and autologous conditioned serum in treatment of knee osteoarthritis.

Authors:  Ali Fotouhi; Arash Maleki; Sanam Dolati; Ali Aghebati-Maleki; Leili Aghebati-Maleki
Journal:  Biomed Pharmacother       Date:  2018-05-25       Impact factor: 6.529

6.  Arthroscopic management and platelet-rich plasma therapy for avascular necrosis of the hip.

Authors:  Jorge Guadilla; Nicolas Fiz; Isabel Andia; Mikel Sánchez
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-06-22       Impact factor: 4.342

7.  Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis.

Authors:  Milva Battaglia; Federica Guaraldi; Francesca Vannini; Giuseppe Rossi; Antonio Timoncini; Roberto Buda; Sandro Giannini
Journal:  Orthopedics       Date:  2013-12       Impact factor: 1.390

8.  Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid-related mechanism.

Authors:  Fiorella Descalzi; Valentina Ulivi; Ranieri Cancedda; Fabiana Piscitelli; Livio Luongo; Francesca Guida; Luisa Gatta; Sabatino Maione; Vincenzo Di Marzo
Journal:  Tissue Eng Part A       Date:  2013-06-06       Impact factor: 3.845

9.  Mesenchymal Stem Cell Alterations in Bone Marrow Lesions in Patients With Hip Osteoarthritis.

Authors:  T Mark Campbell; Sarah M Churchman; Alejandro Gomez; Dennis McGonagle; Philip G Conaghan; Frederique Ponchel; Elena Jones
Journal:  Arthritis Rheumatol       Date:  2016-07       Impact factor: 10.995

10.  Single- and double-dose of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: A randomized controlled trial.

Authors:  Mehdi Tavassoli; Nasser Janmohammadi; Akram Hosseini; Soraya Khafri; Seyed Mokhtar Esmaeilnejad-Ganji
Journal:  World J Orthop       Date:  2019-09-18
View more
  1 in total

1.  Office-Based Intraosseous Infiltrations of PRGF in Knee Osteoarthritis: Description of Technique.

Authors:  Antonio Ríos Luna; Homid Fahandezh-Saddi Díaz; Manuel Villanueva Martinez; Roberto Prado; Sabino Padilla; Eduardo Anitua
Journal:  Arthrosc Tech       Date:  2022-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.